The company sold shares at $6.50 each, well below its closing price of $9.10, according to a filing with the Securities and Exchange Commission (SEC). The raise also included warrants - instruments that give investors the right to buy additional shares later at a set price, in this case as low as $6. The financing came from existing backer Ares Management and several unnamed institutional investors.
Redwire focuses on space infrastructure and autonomous systems. The company completed its Edge Autonomy acquisition and reported 50.7% year-over-year revenue growth. Management maintained full-year guidance of $320 to $340 million, and the book-to-bill ratio of 1.25 suggests demand is holding. But the business is bleeding cash with a net loss of $41.2 million in Q3, nearly double the $21 million loss from the prior year. Gross margin sits at just 16.3%, leaving almost no room for error.
The quantum computing stocks boomed for most of 2025, only to go bust in the last quarter. In 2026, it's been mostly looking lower for many of the top quantum plays, including some of the more speculative plays. That said, the technology is still worth keeping tabs on, even as the quantum pure-play stocks continue to take more backward steps. Of course, investors have taken on more of a risk-off approach in the past couple of quarters.
What mattered more than the headline miss was what the numbers revealed about the underlying business: electrolyzer revenue surged 46% sequentially, but the company's gross losses actually narrowed. That's the real story here. The GenEco electrolyzer segment delivered the quarter's bright spot. Revenue hit $65M, up 46% from Q2 2025, with over 230 MW of electrolyzers now mobilized globally. This is exactly what management has been banking on to drive future profitability. The segment's sequential growth suggests real commercial traction in hydrogen production equipment.
